Voloridge Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Voloridge Investment Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-370,116	Closed	-$2.15M	–	1115
2026 Q1	$2.15M	Sell	370,116 -441,013	-54%	-$2.92M	0.01%	816
2025 Q4	$6.37M	Sell	811,129 -223,424	-22%	-$1.76M	0.02%	704
2025 Q3	$8.42M	Buy	1,034,553 +40,172	+4%	+$267K	0.03%	594
2025 Q2	$4.64M	Sell	994,381 -356,733	-26%	-$1.63M	0.02%	766
2025 Q1	$7.42M	Buy	+1,351,114	New	+$5.45M	0.03%	670
2021 Q1	–	Sell	-134,737	Closed	-$663K	–	1699
2020 Q4	$663K	Sell	134,737 -284,301	-68%	-$1.42M	0.01%	1078
2020 Q3	$2.48M	Buy	+419,038	New	+$1.68M	0.02%	651

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Voloridge Investment Management's XERS Position: Q2 2026 in Review

Voloridge Investment Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 370,116 shares — an estimated $2.15M sold.

Voloridge Investment Management first reported a position in XERS in Q3 2020 and held it in 7 quarters. The position peaked at $8.42M in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Voloridge Investment Management reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Voloridge Investment Management sold 370,116 Xeris Biopharma Holdings shares in Q2 2026, an estimated $2.15M.
Voloridge Investment Management first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 7 quarters.
Voloridge Investment Management's Xeris Biopharma Holdings position peaked at $8.42M in Q3 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.